Skip to main content

Table 15 Subgroup analysis for inclusion criteria

From: Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis

Author

Year

Verum

Verum

Placebo

 

Participants

Responders

Participants

Responders

Group A: Clinical depression as an inclusion criterion

Costa

1985

Mianserin

36

28

37

18

Van Heeringen

1996

Mianserin

28

19

27

10

Razavi

1996

Fluoxetine

35

8

46

9

Musselmann

2006

Paroxetine/desipramine

24

11

11

6

Total

  

133

66

121

43

Group B: Clinical depression not as an inclusion criterion

Fisch

2003

Fluoxetine

64

31

65

23

Total

  

64

31

65

23

  1. RR(A)= 1.42, RR(B)= 1.37 (Zdiff= 0.19, p=0.85).